CAS 1123231-07-1

MAY-262611

CAS : 1123231-07-1

Formule : C₂₀H₂₂N₄

Degré de pureté : 99%

Couleur et forme : Solid

Masse moléculaire : 318.4155

Ref: IN-DA008TKM

WAY-262611

CAS : 1123231-07-1

WAY-262611

Degré de pureté : ≥98%

Masse moléculaire : 318.42g/mol

Ref: 54-BUP06434

WAY-262611

CAS : 1123231-07-1

WAY262611 is a Wnt/β-catenin agonist and an inhibitor of Dkk1. It increases bone formation rate with EC50 of 0.63 μM in TCF-luciferase assay.

Formule : C₂₀H₂₂N₄

Degré de pureté : 98.09% - 99.09%

Couleur et forme : Solid

Masse moléculaire : 318.42

Ref: TM-T1971

WAY-262611

CAS : 1123231-07-1

WAY-262611 is a synthetic small-molecule compound, which is an experimental pharmacological agent originally sourced from chemical libraries aimed at modulating bone biology. This compound acts as an antagonist of the Wnt signaling pathway, specifically targeting low-density lipoprotein receptor-related protein 5 (LRP5). By inhibiting the binding of Wnt proteins, WAY-262611 modulates downstream signaling events, leading to alterations in gene expression that influence bone mass and density.

Formule : C₂₀H₂₂N₄

Degré de pureté : Min. 95%

Masse moléculaire : 318.42 g/mol

Ref: 3D-YUB23107